Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Moodys
Medtronic
Express Scripts
Mallinckrodt

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR DEFINITY RT


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Definity Rt

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00162058 ↗ A Phase II Study of DMP 115 to Assess Focal Liver Lesions Completed Lantheus Medical Imaging Phase 2 2004-03-01 To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions.
NCT00162370 ↗ A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease Completed Lantheus Medical Imaging Phase 4 2004-04-01 The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.
NCT00239525 ↗ 3-D Transcranial Ultrasound Analysis Study Completed Duke University N/A 2006-05-01 The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke.
NCT00401687 ↗ DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function Completed Lantheus Medical Imaging Phase 4 2006-07-01 The purpose of this clinical research study is to demonstrate the ability of Definity┬« enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Definity Rt

Condition Name

Condition Name for Definity Rt
Intervention Trials
Breast Cancer 5
Hepatocellular Carcinoma 4
Coronary Artery Disease 3
Kidney Cancer 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Definity Rt
Intervention Trials
Heart Diseases 5
Carcinoma, Renal Cell 5
Carcinoma 5
Renal Insufficiency, Chronic 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Definity Rt

Trials by Country

Trials by Country for Definity Rt
Location Trials
United States 106
Canada 3
United Kingdom 1
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Definity Rt
Location Trials
Pennsylvania 14
North Carolina 12
California 11
Minnesota 8
Texas 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Definity Rt

Clinical Trial Phase

Clinical Trial Phase for Definity Rt
Clinical Trial Phase Trials
Phase 4 10
Phase 3 4
Phase 2/Phase 3 2
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Definity Rt
Clinical Trial Phase Trials
Completed 29
Recruiting 13
Withdrawn 5
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Definity Rt

Sponsor Name

Sponsor Name for Definity Rt
Sponsor Trials
Lantheus Medical Imaging 18
Thomas Jefferson University 7
National Cancer Institute (NCI) 6
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Definity Rt
Sponsor Trials
Other 77
Industry 26
NIH 12
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKinsey
Johnson and Johnson
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.